Clefamide

Clefamide

Clinical data
Trade names	Mebinol
ATC code	P01AC02 (WHO)
Identifiers
IUPAC name 2,2-Dichloro-N-(2-hydroxyethyl)-N-[[4-(4-nitrophenoxy)phenyl]methyl]
CAS Number	3576-64-5
PubChem CID	71819
ChemSpider	64843 Y
UNII	4AZ2V8K4EK
KEGG	D07354 Y
ChEMBL	ChEMBL1788400
E number	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C17H16Cl2N2O5
Molar mass	399.22 g·mol−1
3D model (JSmol)	Interactive image
SMILES ClC(Cl)C(=O)N(CCO)Cc2ccc(Oc1ccc(cc1)[N+]([O-])=O)cc2
InChI InChI=1S/C17H16Cl2N2O5/c18-16(19)17(23)20(9-10-22)11-12-1-5-14(6-2-12)26-15-7-3-13(4-8-15)21(24)25/h1-8,16,22H,9-11H2 Y Key:ODCUSWJXZDHLKV-UHFFFAOYSA-N Y
(verify)

Clefamide (trade name Mebinol) is an antiprotozoal agent that was used to treat amoebiasis in the 1960s. There is no evidence for any later use of the drug.